| Protocol No. | Title | Status |
| 02-0785-01 | CORE A: TISSUE RESOURCE (SPORE IN GI CANCER) | Open |
| 06-0796-04 | INITIATION OF HELICOBACTOR PYLORI STRAINS FROM HUMAN GASTRODUODENOSCOPY BIOPSIES | Open |
| 07-0612-04 | Phase I Study of Concomitant Pemetrexed and CDDP Plus Radiation Therapy in Patients with Locally Advanced or Metastatic Esophageal or Gastroesophageal (GEJ) Carcinomas | Open |
| 08-1063-04 | Pilot Study to Examine the Effect of Over-the-Counter Supplements on Blood Nutrient Levels | Open |
| 11-0432-04 | S1005: A Phase II Study of MK-2206 (NSC-749607) as Second Line Therapy for Advanced Gastric and Gastroesophageal Junction Cancer
| Open |
| 20121103 | A Phase 3, Multicenter, Randomized, Double-Blind, Placebo Controlled Study of Rilotumumab (AMG 102) with Epirubicin, Cisplatin, and Capecitabine (ECX) as First-line Therapy in Advanced MET-Positive Gastric or Gastroesophageal Junction Adenocarcinoma | Open |
| COGAGCT0521 | Treatment of Recurrent or Resistant Pediatric Malignant Germ Cell Tumors with Paclitaxel, Ifosfamide and Carboplatin (COG AGCT0521) | Open |